| Literature DB >> 29892505 |
Ben A Evans1, Olivia L Smith1, Ethan S Pickerill1, Mary K York1, Kristen J P Buenconsejo2, Antonio E Chambers1, Douglas A Bernstein1.
Abstract
Introduction of point mutations to a gene of interest is a powerful tool when determining protein function. CRISPR-mediated genome editing allows for more efficient transfer of a desired mutation into a wide range of model organisms. Traditionally, PCR amplification and DNA sequencing is used to determine if isolates contain the intended mutation. However, mutation efficiency is highly variable, potentially making sequencing costly and time consuming. To more efficiently screen for correct transformants, we have identified restriction enzymes sites that encode for two identical amino acids or one or two stop codons. We used CRISPR to introduce these restriction sites directly upstream of the Candida albicans UME6 Zn2+-binding domain, a known regulator of C. albicans filamentation. While repair templates coding for different restriction sites were not equally successful at introducing mutations, restriction digest screening enabled us to rapidly identify isolates with the intended mutation in a cost-efficient manner. In addition, mutated isolates have clear defects in filamentation and virulence compared to wild type C. albicans. Our data suggest restriction digestion screening efficiently identifies point mutations introduced by CRISPR and streamlines the process of identifying residues important for a phenotype of interest.Entities:
Keywords: C. albicans; CRISPR; Filamentation; Restriction digestion; Site-directed mutagenesis
Year: 2018 PMID: 29892505 PMCID: PMC5994162 DOI: 10.7717/peerj.4920
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Oligos used in this study.
Restriction Sites Sequences are bolded and capitalized in repair templates. Nucleotides added for cloning into the CRISPR plasmids are bolded and italicized in the guide primer sequences.
| Oligo name | Primer sequence | Restriction site |
|---|---|---|
| Ume6 Guide 2 fr | XXXXXX | |
| Ume6 Guide 2 rv | XXXXXX | |
| Ume6 ch primer 2 fr | ggtcatgatcatgatgatgaaaat | XXXXXX |
| Ume6 ch primer 2 rv | ctccacaaattggtgtgacttc | XXXXXX |
| Ume6 rp 2_Glu fr | atggcactaacaccaatactgattctacttctacttctaatccaatggtg | BseRI |
| Ume6 rp 2_Glu rv | catccttttttagatctaggtaataatcttcttcttgtatgttt | BseRI |
| Ume6 rp 2_TAA fr | aatggcactaacaccaatactgattctacttctacttctaatccaatggt | Pac1 |
| Ume2 rp 2_TAA rv | tccttttttagatctaggtaataatcttcttcttgtatgttt | Pac1 |
| Ume6 rp 2_TGA fr | atggcactaacaccaatactgattctacttctacttctaatccaatggt | Acu1 |
| Ume6 rp 2_TGA rv | acatccttttttagatctaggtaataatcttcttcttgtatgttt | Acu1 |
Restriction sites that encode consecutive amino acids or stop codons.
Nucleotide code is as follows: W = A or T, M = A or C, K = G or T, R = A or G, N = A T C or G, / = cleavage site. Numbers in parentheses correspond to how far downstream a cut site will occur from the recognition sequence.
| Translation product | Codon | Restriction enzyme recognition site sequence |
|---|---|---|
| 2×Alanine | GCN | |
| 2×Arginine | CGN | |
| 2×Glutamate | GAR | |
| 2×Glycine | GGC+GGA | |
| 1×Stop Codon | TAG | |
| 1×Stop Codon | TAA | |
| 1×Stop Codon | TGA | |
| 2×Stop Codon | TAG+TAA |
Figure 1Introduction of restriction sites enable efficient screening for correct point mutants.
(A) Cartoon of Ume6 domains and key residues for this study. Red line indicates CRISPR cut site. (B) Restriction digestion of colony PCR of UME6 from representative ume6TAAStop and ume6-EE C. albicans. Lane 1. Ladder, 2. ume6TAAStop undigested, 3. ume6TAAStop digested with Pac1 4. ume6-EE undigested 5. ume6-EE digested with BseRI C-E. Sequence analysis of site of ume6 mutagenesis of representative failed mutant (wild type sequence) (C), ume6-EE (D), and ume6TAAStop (E) C. albicans amino acid sequence is presented above DNA sequence. Red E designates site of lysine-to-glutamate point mutations. Red octagon designates site of introduced stop codon.
Strains used in this study.
| Name | Genotype | How strain is referenced in text |
|---|---|---|
| SC5314 | Wild Type | |
| DAB898 | ||
| DAB894 |
Figure 2Assessment of UME6 mutations on filamentation and virulence.
(A) Wild type, ume6-EE, and ume6-stopTAA C. albicans were cultured on Spider media at 30 and 37 °C for 7 days and assessed for filamentation. (B) Fourfold serial dilutions of wild type, ume6-EE, and ume6-stopTAA C. albicans were incubated on YPD media at 37 °C for three days. (C) Wild Type and ume6-stopTAA incubated in liquid Spider media were assessed for filamentation after 24 hours. (D) 105 cfu of wild type, ume6-EE, and UME6-stopTAA C. albicans were injected into wax moth larvae, which were subsequently incubated at 37 °C. Survival of larvae was tracked over time. Wt was more virulent than ume6-EE (P = 0.036) and more virulent than ume6-stopTAA as well (P < 0.001). Additionally ume6-EE was more virulent than ume6-stopTAA (P = 0.003). Results represent total survival of five independent experiments with 10 larvae per treatment. Survival curves were created using the Kaplan–Meier method and statistical analyses were performed using the log rank test for multiple comparisons (IBM SPSS Statistics; SPSS, Armonk, NY, USA).